- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Neoprobe arranges Israeli agent plant
Neoprobe is establishingan Israeli subsidiary to run a radiolabeling facility for monoclonalantibody agents used in its nuclear probe technology (see above).The U.S. firm signed a memorandum of understanding with the Israelifirm Rotem Industries in
Neoprobe is establishingan Israeli subsidiary to run a radiolabeling facility for monoclonalantibody agents used in its nuclear probe technology (see above).The U.S. firm signed a memorandum of understanding with the Israelifirm Rotem Industries in January. Neoprobe will own 95% of Neoprobe-Israeland Rotem the rest.
Located near Temed, Neoprobe-Israel will produce radiolabeledantibodies for use with its RIGS technology in Europe and Israel.The company will also serve as a secondary source of supply forRIGS agents, in addition to Nordion of Canada. Neoprobe has signeda long-term supply agreement with Nordion.
The move is a logical follow-up to its acquisition of MonoCarbAB of Sweden last December, said Neoprobe president David Bupp.
"Neoprobe now has complete control of all aspects of manufacturingand distributing RIGS surgical system targeting agents,"he said.
The agreement with Rotem is contingent on the government ofIsrael providing $3 million in guarantees to help fund the facilityand clinical testing of agents developed there.
Can AI Enhance CT Detection of Incidental Extrapulmonary Abnormalities and Prediction of Mortality?
September 18th 2024Emphasizing multi-structure segmentation and feature extraction from chest CT scans, an emerging AI model demonstrated an approximately 70 percent AUC for predicting significant incidental extrapulmonary findings as well as two-year and 10-year all-cause mortality.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.
